Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetics of Lacosamide in Korean Patients With Epilepsy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy
Epilepsia 2022 Aug 21;[EPub Ahead of Print], SJ Ahn, J Oh, DY Kim, H Son, S Hwang, HR Shin, EY Kim, HS Lee, WJ Lee, J Moon, ST Lee, KH Jung, KI Park, KY Jung, S Lee, KS Yu, K Chu, SK LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.